CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

OBJECTIVE: The diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) must be improved before widespread clinical use. This study aimed to determine whether CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios are better diagnostic biomarkers of AD during both predementia and de...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Clin Transl Neurol
Auteurs principaux: Janelidze, Shorena, Zetterberg, Henrik, Mattsson, Niklas, Palmqvist, Sebastian, Vanderstichele, Hugo, Lindberg, Olof, van Westen, Danielle, Stomrud, Erik, Minthon, Lennart, Blennow, Kaj, Hansson, Oskar
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774260/
https://ncbi.nlm.nih.gov/pubmed/27042676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.274
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires